Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in Chinese patients with rheumatoid arthritis
NCT00647920Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2003
- Primary completion
- Apr 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Trudexa in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Jul 2003; status: completed.
02
Drugs
Trudexa
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00647920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647920.